A contemporary analysis of disease upstaging of Gleason 3 + 3 prostate cancer patients after robot‐assisted laparoscopic prostatectomy

Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)

(2022) Janet Athene Lane et al.   BJU INTERNATIONAL

Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS–JAPAN study

(2022) Yoichiro Tohi et al.   International Journal of Clinical Oncology

The Surgical Learning Curve for Biochemical Recurrence After Robot-assisted Radical Prostatectomy

(2022) Carlo A. Bravi et al.   European Urology Oncology

Prostate cancer

(2021) Shahneen Sandhu et al.   LANCET

Prostate MRI–TRUS fusion biopsy: a review of the state of the art procedure

(2020) Chandan J. Das et al.   Abdominal Radiology

The pathological upgrading after radical prostatectomy in low‐risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?

(2019) Samed Verep et al.   PROSTATE

The Diagnosis and Treatment of Prostate Cancer

(2017) Mark S. Litwin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

(2017) Hashim U Ahmed et al.   LANCET

Population-based study of grade progression in patients who harboured Gleason 3 + 3

(2017) Fanny Sampurno et al.   WORLD JOURNAL OF UROLOGY

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

(2016) Freddie C. Hamdy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gleason and Fuhrman no longer make the grade

(2015) Brett Delahunt et al.   HISTOPATHOLOGY

Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer

(2015) Laurence Klotz et al.   JOURNAL OF CLINICAL ONCOLOGY

Upgrading of Gleason score and prostate volume: a clinicopathological analysis

(2013) Kwang Hyun Kim et al.   BJU INTERNATIONAL

Role of multiparametric 3.0-Tesla magnetic resonance imaging in patients with prostate cancer eligible for active surveillance

(2013) Bong H. Park et al.   BJU INTERNATIONAL

SHOULD WE REALLY CONSIDER GLEASON 6 PROSTATE CANCER?

(2011) J. Curtis Nickel et al.   BJU INTERNATIONAL

Smaller prostate gland size and older age predict Gleason score upgrading

(2011) Boris Gershman et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS